Short interest screen · refreshed after the Sep 28, 2026 close
Highest days to cover: Healthcare
Short positions that would take the longest to unwind at normal trading volume. Days to cover divides the shares sold short by average daily volume. A higher number means short sellers would need more time to buy back shares, which can make a rally sharper.
| # | Company | Price | Today | Days to cover | Short % float | Δ short int. | Mkt cap |
|---|---|---|---|---|---|---|---|
| 351 | IRTCiRhythm HoldingsHealthcare | $112.60 | +2.01% | 5.6 | 9.4% | +10% | $3.71B |
| 352 | PRCTPROCEPT BioRoboticsHealthcare | $17.25 | +0.29% | 5.6 | 14.1% | +3% | $988.0M |
| 353 | GEHCGE HealthCare TechnologiesHealthcare | $66.78 | +0.23% | 5.5 | 3.8% | −11% | $30.16B |
| 354 | BMRNBioMarin PharmaceuticalsHealthcare | $59.46 | −1.33% | 5.5 | 5.2% | +2% | $11.51B |
| 355 | OGNOrganon &Healthcare | $13.73 | 0.00% | 5.5 | 6.7% | +5% | $3.61B |
| 356 | RXSTRxSightHealthcare | $4.67 | +0.21% | 5.5 | 10.1% | +3% | $194.2M |
| 357 | SIGASIGA TechnologiesHealthcare | $3.46 | +0.29% | 5.5 | 9.2% | +5% | $248.6M |
| 358 | ATECAlphatec HoldingsHealthcare | $10.05 | −0.69% | 5.5 | 11.6% | +6% | $1.55B |
| 359 | NKTXNkartaHealthcare | $2.67 | −2.91% | 5.5 | 8.3% | +2% | $191.2M |
| 360 | DYNDyne TherapeuticsHealthcare | $16.34 | +1.93% | 5.5 | 13.4% | +12% | $3.05B |
| 361 | AORTArtivionHealthcare | $22.95 | +1.41% | 5.4 | 7.2% | +12% | $1.12B |
| 362 | CHEChemedHealthcare | $514.30 | +0.42% | 5.4 | 5.1% | +16% | $6.72B |
| 363 | NBIXNeurocrine BiosciencesHealthcare | $140.44 | +1.47% | 5.4 | 5.1% | −2% | $14.28B |
| 364 | ANIKAnika TherapeuticsHealthcare | $20.68 | +1.52% | 5.4 | 3.3% | +10% | $276.8M |
| 365 | PACSPACS GroupHealthcare | $43.06 | +4.26% | 5.3 | 8.1% | +12% | $6.82B |
| 366 | INSMInsmedHealthcare | $117.67 | −0.14% | 5.3 | 5.0% | −6% | $25.70B |
| 367 | VMDViemed HealthcareHealthcare | $9.11 | +2.24% | 5.2 | 4.1% | +10% | $347.0M |
| 368 | ZNTLZentalis PharmaceuticalsHealthcare | $2.60 | −3.70% | 5.2 | 9.6% | −4% | $246.1M |
| 369 | TLRYTilray BrandsHealthcare | $4.02 | −2.66% | 5.2 | 14.4% | +8% | $564.5M |
| 370 | PEPGPepGenHealthcare | $2.59 | 0.00% | 5.2 | 9.7% | +5% | $179.4M |
| 371 | FHTXFoghorn TherapeuticsHealthcare | $3.52 | +0.57% | 5.2 | 5.9% | +1% | $209.0M |
| 372 | CABACabaletta BioHealthcare | $2.00 | −3.38% | 5.2 | 24.4% | −20% | $339.1M |
| 373 | IONSIonis PharmaceuticalsHealthcare | $45.57 | +2.40% | 5.2 | 12.8% | 0% | $7.57B |
| 374 | DFTXDefinium TherapeuticsHealthcare | $38.41 | +6.19% | 5.2 | 11.0% | +20% | $5.16B |
| 375 | AXSMAxsome TherapeuticsHealthcare | $193.89 | −0.62% | 5.2 | 7.8% | +2% | $10.16B |
| 376 | WVEWave Life SciencesHealthcare | $3.67 | −2.91% | 5.2 | 14.2% | +8% | $723.2M |
| 377 | SRTAStrata Critical MedicalHealthcare | $5.23 | −1.88% | 5.2 | 6.2% | −4% | $462.7M |
| 378 | ARWRArrowhead ResearchHealthcare | $65.46 | −0.70% | 5.2 | 6.8% | −2% | $9.25B |
| 379 | QTTBQ32 BioHealthcare | $9.23 | +5.25% | 5.2 | 30.6% | +6% | $274.8M |
| 380 | INGNInogenHealthcare | $5.44 | +1.49% | 5.1 | 5.9% | −7% | $144.4M |
| 381 | IMUXImmunicHealthcare | $9.51 | +1.77% | 5.0 | 1.5% | +20% | $129.8M |
| 382 | VTVTvTv TherapeuticsHealthcare | $30.52 | +1.03% | 5.0 | 10.8% | −2% | $120.7M |
| 383 | VRTXVertex PharmaceuticalsHealthcare | $527.67 | +0.28% | 5.0 | 1.9% | +1% | $133.74B |
| 384 | ABUSArbutus BiopharmaHealthcare | $4.86 | +0.21% | 5.0 | 11.8% | −2% | $962.8M |
Data guard: 9 stocks withheld — NG (reported short interest is above 100% of float); EGO (reported short interest is above 100% of float); BNS (reported short interest is above 100% of float); AQN (reported short interest is above 100% of float); CAE (reported short interest is above 100% of float); GIL (reported short interest is above 100% of float); EPRX (reported short interest is above 100% of float); MFI (reported short interest is above 100% of float); CHRN (float record is implausibly small). They return once the float record is verified.
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.